Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 18, 2007 - Issue 3
Submit an article Journal homepage
122
Views
21
CrossRef citations to date
0
Altmetric
CASE REPORT

Treatment of refractory pemphigus vulgaris with anti‐CD20 monoclonal antibody (rituximab): Five cases

Angela Antonucci Department of Specialistic and Experimental Clinical Medicine, Division of Dermatology, University of Bologna, ItalyCorrespondence[email protected]
,
Massimino Negosanti Department of Specialistic and Experimental Clinical Medicine, Division of Dermatology, University of Bologna, Italy
,
Michela Tabanelli Department of Specialistic and Experimental Clinical Medicine, Division of Dermatology, University of Bologna, Italy
&
Claudio Varotti Department of Specialistic and Experimental Clinical Medicine, Division of Dermatology, University of Bologna, Italy
Pages 178-183 | Received 31 Oct 2006, Accepted 14 Feb 2007, Published online: 12 Jul 2009

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Burçin Cansu Bozca, Aslı Bilgiç & Soner Uzun. (2022) Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus. Journal of Dermatological Treatment 33:4, pages 2102-2109.
Read now
Ron J Feldman & A Razzaque Ahmed. (2011) Relevance of rituximab therapy in pemphigus vulgaris: analysis of current data and the immunologic basis for its observed responses. Expert Review of Clinical Immunology 7:4, pages 529-541.
Read now
Jennifer D Peterson & Lawrence S Chan. (2009) Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: A comprehensive survey of 71 consecutive patients from the Initial use to 2007. Therapeutics and Clinical Risk Management 5, pages 1-7.
Read now
Enno Schmidt & Matthias Goebeler. (2008) CD20-directed therapy in autoimmune diseases involving the skin: role of rituximab. Expert Review of Dermatology 3:3, pages 259-278.
Read now

Articles from other publishers (17)

Oleg V. Karzanov, Ekaterina V. Chernyaeva, Anna G. Kupriyanova, Yulia V. Molochkova, Elena V. Zenkevich & Anton V. Molochkov. (2022) B-cell depletion in the treatment of pemphigus: two clinical cases and literature review. Almanac of Clinical Medicine.
Crossref
Vivien Hebert & Pascal Joly. (2018) Rituximab in pemphigus. Immunotherapy 10:1, pages 27-37.
Crossref
Soheil Tavakolpour, HamidReza Mahmoudi, Kamran Balighi, Robabeh Abedini & Maryam Daneshpazhooh. (2018) Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review. International Immunopharmacology 54, pages 131-138.
Crossref
Crispian Scully. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition 1 144 .
Mimansa Cholera & Nita Chainani-Wu. (2016) Management of Pemphigus Vulgaris. Advances in Therapy 33:6, pages 910-958.
Crossref
A. Razzaque Ahmed & Shawn Shetty. (2015) The Emerging Role of Rituximab in Autoimmune Blistering Diseases. American Journal of Clinical Dermatology 16:3, pages 167-177.
Crossref
K.T. Amber & M. Hertl. (2015) An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab. Journal of the European Academy of Dermatology and Venereology 29:4, pages 777-782.
Crossref
A. Razzaque Ahmed & Shawn Shetty. (2015) A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab. Autoimmunity Reviews 14:4, pages 323-331.
Crossref
S. Gregoriou, S. Giatrakou, K. Theodoropoulos, A. Katoulis, P. Loumou, E. Toumbis-Ioannou, E. Papadavid, G. Avgerinou, N. Stavrianeas & D. Rigopoulos. (2014) Pilot Study of 19 Patients with Severe Pemphigus: Prophylactic Treatment with Rituximab Does Not Appear to be Beneficial. Dermatology 228:2, pages 158-165.
Crossref
Crispian Scully. 2014. Scully's Medical Problems in Dentistry. Scully's Medical Problems in Dentistry 481 497 .
Balighi Kamran, Daneshpazhooh Maryam, Khezri Somayeh, Mahdavi-nia Mostafa, Hajiseyed-javadi Mahsa & Chams-Davatchi Cheyda. (2013) Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial. International Journal of Dermatology 52:7, pages 862-867.
Crossref
Labib R. Zakka, Shawn S. Shetty & A. Razzaque Ahmed. (2012) Rituximab in the Treatment of Pemphigus Vulgaris. Dermatology and Therapy 2:1.
Crossref
N Cirillo, E Cozzani, M Carrozzo & SA Grando. (2012) Urban legends: pemphigus vulgaris. Oral Diseases 18:5, pages 442-458.
Crossref
C. Scully & A. Hegarty. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology 1 129 .
Thomas Dörner, David Isenberg, David Jayne, Heinz Wiendl, Detlef Zillikens & Gerd Burmester. (2009) Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis. Autoimmunity Reviews 9:2, pages 82-89.
Crossref
G. Guhl, B. Díaz-Ley & J. Fernández-Herrera. (2008) Uso de fármacos biológicos en dermatosis fuera de la indicación aprobada. Segunda parte: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab y cetuximab. Actas Dermo-Sifiliográficas 99:1, pages 5-33.
Crossref
G. Guhl, B. Díaz-Ley & J. Fernández-Herrera. (2008) Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 2: Etanercept, Efalizumab, Alefacept, Rituximab, Daclizumab, Basiliximab, Omalizumab, and Cetuximab. Actas Dermo-Sifiliográficas (English Edition) 99:1, pages 5-33.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.